Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-06

Clinical Trial Update: Preoperative Bevacizumab Injection in Primary Pterygium in Tunisian Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing preoperative bevacizumab injection for pterygium in Tunisian patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bevacizumab (bevacizumab)

Snippet

Sponsor: University Hospital Fattouma Bourguiba | Conditions: Pterygium | Phase 4 | Status: COMPLETED